DOTmed February 23, 2024
2023 stood out as a turning point for the breast imaging market, due to the diminished impact of COVID-19 and a rebalance in market demand. In 2022, breast imaging revenue was down 17.6% compared to 2021 as vendors suffered a shortage of semi-conductors, inflation hikes, and a market correction following elevated investment on breast imaging systems in 2021 as budgets returned post-COVID.
Overall, breast imaging revenue grew 12.5% in 2023 and is forecast to reach $1.18 billion by 2027. This is driven by introduction of novel screening programs, digitalisation within developing countries, and an increasing proportion of digital breast tomosynthesis (DBT) and automated breast ultrasound (ABUS) system purchases.
Currently, DBT accounts for over half of the global breast imaging market’s...
Today's Sponsors
Today's Sponsor